nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CHRM3—muscle of abdomen—stomach cancer	0.0202	0.408	CbGeAlD
Cevimeline—FMO1—digestive system—stomach cancer	0.00446	0.0899	CbGeAlD
Cevimeline—FMO1—endocrine gland—stomach cancer	0.00368	0.0743	CbGeAlD
Cevimeline—FMO1—liver—stomach cancer	0.00332	0.067	CbGeAlD
Cevimeline—FMO1—lymph node—stomach cancer	0.00255	0.0513	CbGeAlD
Cevimeline—CHRM3—smooth muscle tissue—stomach cancer	0.00232	0.0468	CbGeAlD
Cevimeline—CHRM3—digestive system—stomach cancer	0.00183	0.0369	CbGeAlD
Cevimeline—CHRM1—endocrine gland—stomach cancer	0.00169	0.0341	CbGeAlD
Cevimeline—CHRM3—endocrine gland—stomach cancer	0.00151	0.0305	CbGeAlD
Cevimeline—CYP3A4—hematopoietic system—stomach cancer	0.00145	0.0292	CbGeAlD
Cevimeline—CYP2D6—hematopoietic system—stomach cancer	0.00142	0.0287	CbGeAlD
Cevimeline—CYP3A4—digestive system—stomach cancer	0.00101	0.0203	CbGeAlD
Cevimeline—CYP2D6—digestive system—stomach cancer	0.00099	0.02	CbGeAlD
Cevimeline—CYP3A4—endocrine gland—stomach cancer	0.000831	0.0168	CbGeAlD
Cevimeline—CYP2D6—endocrine gland—stomach cancer	0.000818	0.0165	CbGeAlD
Cevimeline—CYP3A4—liver—stomach cancer	0.00075	0.0151	CbGeAlD
Cevimeline—CYP2D6—liver—stomach cancer	0.000738	0.0149	CbGeAlD
Cevimeline—Sinusitis—Doxorubicin—stomach cancer	0.000293	0.00035	CcSEcCtD
Cevimeline—Dizziness—Fluorouracil—stomach cancer	0.000292	0.000349	CcSEcCtD
Cevimeline—Visual impairment—Epirubicin—stomach cancer	0.000292	0.000348	CcSEcCtD
Cevimeline—Agranulocytosis—Doxorubicin—stomach cancer	0.000291	0.000348	CcSEcCtD
Cevimeline—Rash—Irinotecan—stomach cancer	0.000291	0.000347	CcSEcCtD
Cevimeline—Dermatitis—Irinotecan—stomach cancer	0.000291	0.000347	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.00029	0.000347	CcSEcCtD
Cevimeline—Chills—Methotrexate—stomach cancer	0.00029	0.000347	CcSEcCtD
Cevimeline—Headache—Irinotecan—stomach cancer	0.000289	0.000345	CcSEcCtD
Cevimeline—Hypotension—Capecitabine—stomach cancer	0.000288	0.000345	CcSEcCtD
Cevimeline—Insomnia—Docetaxel—stomach cancer	0.000288	0.000344	CcSEcCtD
Cevimeline—Paraesthesia—Docetaxel—stomach cancer	0.000286	0.000342	CcSEcCtD
Cevimeline—Alopecia—Methotrexate—stomach cancer	0.000286	0.000341	CcSEcCtD
Cevimeline—Dyspnoea—Docetaxel—stomach cancer	0.000284	0.00034	CcSEcCtD
Cevimeline—Somnolence—Docetaxel—stomach cancer	0.000283	0.000339	CcSEcCtD
Cevimeline—Eye disorder—Epirubicin—stomach cancer	0.000283	0.000338	CcSEcCtD
Cevimeline—Tinnitus—Epirubicin—stomach cancer	0.000282	0.000337	CcSEcCtD
Cevimeline—Malnutrition—Methotrexate—stomach cancer	0.000282	0.000336	CcSEcCtD
Cevimeline—Haemoglobin—Doxorubicin—stomach cancer	0.000281	0.000336	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000281	0.000336	CcSEcCtD
Cevimeline—Cardiac disorder—Epirubicin—stomach cancer	0.000281	0.000336	CcSEcCtD
Cevimeline—Flushing—Epirubicin—stomach cancer	0.000281	0.000336	CcSEcCtD
Cevimeline—Vomiting—Fluorouracil—stomach cancer	0.000281	0.000335	CcSEcCtD
Cevimeline—Rhinitis—Doxorubicin—stomach cancer	0.000281	0.000335	CcSEcCtD
Cevimeline—Dyspepsia—Docetaxel—stomach cancer	0.000281	0.000335	CcSEcCtD
Cevimeline—Haemorrhage—Doxorubicin—stomach cancer	0.00028	0.000335	CcSEcCtD
Cevimeline—Insomnia—Capecitabine—stomach cancer	0.000279	0.000334	CcSEcCtD
Cevimeline—Hypoaesthesia—Doxorubicin—stomach cancer	0.000279	0.000333	CcSEcCtD
Cevimeline—Rash—Fluorouracil—stomach cancer	0.000278	0.000333	CcSEcCtD
Cevimeline—Dermatitis—Fluorouracil—stomach cancer	0.000278	0.000332	CcSEcCtD
Cevimeline—Pharyngitis—Doxorubicin—stomach cancer	0.000278	0.000332	CcSEcCtD
Cevimeline—Paraesthesia—Capecitabine—stomach cancer	0.000277	0.000331	CcSEcCtD
Cevimeline—Decreased appetite—Docetaxel—stomach cancer	0.000277	0.000331	CcSEcCtD
Cevimeline—Headache—Fluorouracil—stomach cancer	0.000277	0.000331	CcSEcCtD
Cevimeline—Oedema peripheral—Doxorubicin—stomach cancer	0.000276	0.00033	CcSEcCtD
Cevimeline—Dysgeusia—Methotrexate—stomach cancer	0.000276	0.000329	CcSEcCtD
Cevimeline—Dyspnoea—Capecitabine—stomach cancer	0.000275	0.000329	CcSEcCtD
Cevimeline—Fatigue—Docetaxel—stomach cancer	0.000275	0.000328	CcSEcCtD
Cevimeline—Angiopathy—Epirubicin—stomach cancer	0.000275	0.000328	CcSEcCtD
Cevimeline—Urethral disorder—Doxorubicin—stomach cancer	0.000275	0.000328	CcSEcCtD
Cevimeline—Nausea—Irinotecan—stomach cancer	0.000274	0.000327	CcSEcCtD
Cevimeline—Pain—Docetaxel—stomach cancer	0.000273	0.000326	CcSEcCtD
Cevimeline—Constipation—Docetaxel—stomach cancer	0.000273	0.000326	CcSEcCtD
Cevimeline—Back pain—Methotrexate—stomach cancer	0.000272	0.000325	CcSEcCtD
Cevimeline—Dyspepsia—Capecitabine—stomach cancer	0.000272	0.000325	CcSEcCtD
Cevimeline—Chills—Epirubicin—stomach cancer	0.000272	0.000324	CcSEcCtD
Cevimeline—Arrhythmia—Epirubicin—stomach cancer	0.00027	0.000323	CcSEcCtD
Cevimeline—Visual impairment—Doxorubicin—stomach cancer	0.00027	0.000322	CcSEcCtD
Cevimeline—Decreased appetite—Capecitabine—stomach cancer	0.000268	0.000321	CcSEcCtD
Cevimeline—Alopecia—Epirubicin—stomach cancer	0.000267	0.00032	CcSEcCtD
Cevimeline—Fatigue—Capecitabine—stomach cancer	0.000266	0.000318	CcSEcCtD
Cevimeline—Pain—Capecitabine—stomach cancer	0.000264	0.000315	CcSEcCtD
Cevimeline—Constipation—Capecitabine—stomach cancer	0.000264	0.000315	CcSEcCtD
Cevimeline—Malnutrition—Epirubicin—stomach cancer	0.000263	0.000315	CcSEcCtD
Cevimeline—Feeling abnormal—Docetaxel—stomach cancer	0.000263	0.000314	CcSEcCtD
Cevimeline—Nausea—Fluorouracil—stomach cancer	0.000262	0.000313	CcSEcCtD
Cevimeline—Eye disorder—Doxorubicin—stomach cancer	0.000262	0.000313	CcSEcCtD
Cevimeline—Ill-defined disorder—Methotrexate—stomach cancer	0.000261	0.000312	CcSEcCtD
Cevimeline—Tinnitus—Doxorubicin—stomach cancer	0.000261	0.000312	CcSEcCtD
Cevimeline—Gastrointestinal pain—Docetaxel—stomach cancer	0.000261	0.000311	CcSEcCtD
Cevimeline—Anaemia—Methotrexate—stomach cancer	0.00026	0.000311	CcSEcCtD
Cevimeline—Cardiac disorder—Doxorubicin—stomach cancer	0.00026	0.00031	CcSEcCtD
Cevimeline—Flushing—Doxorubicin—stomach cancer	0.00026	0.00031	CcSEcCtD
Cevimeline—Flatulence—Epirubicin—stomach cancer	0.00026	0.00031	CcSEcCtD
Cevimeline—Dysgeusia—Epirubicin—stomach cancer	0.000258	0.000308	CcSEcCtD
Cevimeline—Back pain—Epirubicin—stomach cancer	0.000255	0.000304	CcSEcCtD
Cevimeline—Feeling abnormal—Capecitabine—stomach cancer	0.000254	0.000304	CcSEcCtD
Cevimeline—Angiopathy—Doxorubicin—stomach cancer	0.000254	0.000304	CcSEcCtD
Cevimeline—Malaise—Methotrexate—stomach cancer	0.000254	0.000303	CcSEcCtD
Cevimeline—Muscle spasms—Epirubicin—stomach cancer	0.000253	0.000303	CcSEcCtD
Cevimeline—Vertigo—Methotrexate—stomach cancer	0.000253	0.000302	CcSEcCtD
Cevimeline—Gastrointestinal pain—Capecitabine—stomach cancer	0.000252	0.000302	CcSEcCtD
Cevimeline—Body temperature increased—Docetaxel—stomach cancer	0.000252	0.000301	CcSEcCtD
Cevimeline—Abdominal pain—Docetaxel—stomach cancer	0.000252	0.000301	CcSEcCtD
Cevimeline—Leukopenia—Methotrexate—stomach cancer	0.000252	0.000301	CcSEcCtD
Cevimeline—Chills—Doxorubicin—stomach cancer	0.000251	0.0003	CcSEcCtD
Cevimeline—Arrhythmia—Doxorubicin—stomach cancer	0.00025	0.000299	CcSEcCtD
Cevimeline—Alopecia—Doxorubicin—stomach cancer	0.000247	0.000296	CcSEcCtD
Cevimeline—Cough—Methotrexate—stomach cancer	0.000246	0.000293	CcSEcCtD
Cevimeline—Urticaria—Capecitabine—stomach cancer	0.000245	0.000293	CcSEcCtD
Cevimeline—Ill-defined disorder—Epirubicin—stomach cancer	0.000244	0.000292	CcSEcCtD
Cevimeline—Abdominal pain—Capecitabine—stomach cancer	0.000244	0.000291	CcSEcCtD
Cevimeline—Body temperature increased—Capecitabine—stomach cancer	0.000244	0.000291	CcSEcCtD
Cevimeline—Convulsion—Methotrexate—stomach cancer	0.000244	0.000291	CcSEcCtD
Cevimeline—Malnutrition—Doxorubicin—stomach cancer	0.000244	0.000291	CcSEcCtD
Cevimeline—Anaemia—Epirubicin—stomach cancer	0.000244	0.000291	CcSEcCtD
Cevimeline—Agitation—Epirubicin—stomach cancer	0.000242	0.000289	CcSEcCtD
Cevimeline—Flatulence—Doxorubicin—stomach cancer	0.00024	0.000287	CcSEcCtD
Cevimeline—Myalgia—Methotrexate—stomach cancer	0.00024	0.000286	CcSEcCtD
Cevimeline—Chest pain—Methotrexate—stomach cancer	0.00024	0.000286	CcSEcCtD
Cevimeline—Arthralgia—Methotrexate—stomach cancer	0.00024	0.000286	CcSEcCtD
Cevimeline—Dysgeusia—Doxorubicin—stomach cancer	0.000239	0.000285	CcSEcCtD
Cevimeline—Malaise—Epirubicin—stomach cancer	0.000238	0.000284	CcSEcCtD
Cevimeline—Discomfort—Methotrexate—stomach cancer	0.000237	0.000283	CcSEcCtD
Cevimeline—Vertigo—Epirubicin—stomach cancer	0.000237	0.000283	CcSEcCtD
Cevimeline—Syncope—Epirubicin—stomach cancer	0.000236	0.000282	CcSEcCtD
Cevimeline—Leukopenia—Epirubicin—stomach cancer	0.000236	0.000282	CcSEcCtD
Cevimeline—Back pain—Doxorubicin—stomach cancer	0.000236	0.000282	CcSEcCtD
Cevimeline—Hypersensitivity—Docetaxel—stomach cancer	0.000235	0.000281	CcSEcCtD
Cevimeline—Muscle spasms—Doxorubicin—stomach cancer	0.000234	0.00028	CcSEcCtD
Cevimeline—Palpitations—Epirubicin—stomach cancer	0.000233	0.000278	CcSEcCtD
Cevimeline—Confusional state—Methotrexate—stomach cancer	0.000232	0.000277	CcSEcCtD
Cevimeline—Loss of consciousness—Epirubicin—stomach cancer	0.000232	0.000277	CcSEcCtD
Cevimeline—Cough—Epirubicin—stomach cancer	0.00023	0.000275	CcSEcCtD
Cevimeline—Asthenia—Docetaxel—stomach cancer	0.000229	0.000273	CcSEcCtD
Cevimeline—Convulsion—Epirubicin—stomach cancer	0.000228	0.000273	CcSEcCtD
Cevimeline—Infection—Methotrexate—stomach cancer	0.000228	0.000273	CcSEcCtD
Cevimeline—Hypertension—Epirubicin—stomach cancer	0.000227	0.000272	CcSEcCtD
Cevimeline—Hypersensitivity—Capecitabine—stomach cancer	0.000227	0.000272	CcSEcCtD
Cevimeline—Ill-defined disorder—Doxorubicin—stomach cancer	0.000226	0.00027	CcSEcCtD
Cevimeline—Pruritus—Docetaxel—stomach cancer	0.000226	0.000269	CcSEcCtD
Cevimeline—Nervous system disorder—Methotrexate—stomach cancer	0.000225	0.000269	CcSEcCtD
Cevimeline—Anaemia—Doxorubicin—stomach cancer	0.000225	0.000269	CcSEcCtD
Cevimeline—Thrombocytopenia—Methotrexate—stomach cancer	0.000225	0.000269	CcSEcCtD
Cevimeline—Arthralgia—Epirubicin—stomach cancer	0.000224	0.000268	CcSEcCtD
Cevimeline—Myalgia—Epirubicin—stomach cancer	0.000224	0.000268	CcSEcCtD
Cevimeline—Chest pain—Epirubicin—stomach cancer	0.000224	0.000268	CcSEcCtD
Cevimeline—Agitation—Doxorubicin—stomach cancer	0.000224	0.000268	CcSEcCtD
Cevimeline—Anxiety—Epirubicin—stomach cancer	0.000224	0.000267	CcSEcCtD
Cevimeline—Skin disorder—Methotrexate—stomach cancer	0.000223	0.000267	CcSEcCtD
Cevimeline—Hyperhidrosis—Methotrexate—stomach cancer	0.000222	0.000265	CcSEcCtD
Cevimeline—Discomfort—Epirubicin—stomach cancer	0.000222	0.000265	CcSEcCtD
Cevimeline—Asthenia—Capecitabine—stomach cancer	0.000221	0.000265	CcSEcCtD
Cevimeline—Malaise—Doxorubicin—stomach cancer	0.00022	0.000263	CcSEcCtD
Cevimeline—Vertigo—Doxorubicin—stomach cancer	0.000219	0.000262	CcSEcCtD
Cevimeline—Anorexia—Methotrexate—stomach cancer	0.000219	0.000262	CcSEcCtD
Cevimeline—Syncope—Doxorubicin—stomach cancer	0.000219	0.000261	CcSEcCtD
Cevimeline—Pruritus—Capecitabine—stomach cancer	0.000218	0.000261	CcSEcCtD
Cevimeline—Leukopenia—Doxorubicin—stomach cancer	0.000218	0.000261	CcSEcCtD
Cevimeline—Diarrhoea—Docetaxel—stomach cancer	0.000218	0.000261	CcSEcCtD
Cevimeline—Confusional state—Epirubicin—stomach cancer	0.000217	0.000259	CcSEcCtD
Cevimeline—Palpitations—Doxorubicin—stomach cancer	0.000215	0.000257	CcSEcCtD
Cevimeline—Oedema—Epirubicin—stomach cancer	0.000215	0.000257	CcSEcCtD
Cevimeline—Hypotension—Methotrexate—stomach cancer	0.000215	0.000256	CcSEcCtD
Cevimeline—Loss of consciousness—Doxorubicin—stomach cancer	0.000214	0.000256	CcSEcCtD
Cevimeline—Infection—Epirubicin—stomach cancer	0.000214	0.000255	CcSEcCtD
Cevimeline—Cough—Doxorubicin—stomach cancer	0.000213	0.000254	CcSEcCtD
Cevimeline—Shock—Epirubicin—stomach cancer	0.000212	0.000253	CcSEcCtD
Cevimeline—Convulsion—Doxorubicin—stomach cancer	0.000211	0.000252	CcSEcCtD
Cevimeline—Diarrhoea—Capecitabine—stomach cancer	0.000211	0.000252	CcSEcCtD
Cevimeline—Nervous system disorder—Epirubicin—stomach cancer	0.000211	0.000252	CcSEcCtD
Cevimeline—Dizziness—Docetaxel—stomach cancer	0.000211	0.000252	CcSEcCtD
Cevimeline—Thrombocytopenia—Epirubicin—stomach cancer	0.000211	0.000252	CcSEcCtD
Cevimeline—Hypertension—Doxorubicin—stomach cancer	0.00021	0.000251	CcSEcCtD
Cevimeline—Tachycardia—Epirubicin—stomach cancer	0.00021	0.000251	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000209	0.00025	CcSEcCtD
Cevimeline—Skin disorder—Epirubicin—stomach cancer	0.000209	0.00025	CcSEcCtD
Cevimeline—Hyperhidrosis—Epirubicin—stomach cancer	0.000208	0.000248	CcSEcCtD
Cevimeline—Insomnia—Methotrexate—stomach cancer	0.000208	0.000248	CcSEcCtD
Cevimeline—Chest pain—Doxorubicin—stomach cancer	0.000208	0.000248	CcSEcCtD
Cevimeline—Myalgia—Doxorubicin—stomach cancer	0.000208	0.000248	CcSEcCtD
Cevimeline—Arthralgia—Doxorubicin—stomach cancer	0.000208	0.000248	CcSEcCtD
Cevimeline—Anxiety—Doxorubicin—stomach cancer	0.000207	0.000247	CcSEcCtD
Cevimeline—Paraesthesia—Methotrexate—stomach cancer	0.000206	0.000246	CcSEcCtD
Cevimeline—Discomfort—Doxorubicin—stomach cancer	0.000205	0.000245	CcSEcCtD
Cevimeline—Anorexia—Epirubicin—stomach cancer	0.000205	0.000245	CcSEcCtD
Cevimeline—Dyspnoea—Methotrexate—stomach cancer	0.000205	0.000245	CcSEcCtD
Cevimeline—Somnolence—Methotrexate—stomach cancer	0.000204	0.000244	CcSEcCtD
Cevimeline—Dizziness—Capecitabine—stomach cancer	0.000204	0.000244	CcSEcCtD
Cevimeline—Vomiting—Docetaxel—stomach cancer	0.000203	0.000242	CcSEcCtD
Cevimeline—Dyspepsia—Methotrexate—stomach cancer	0.000202	0.000242	CcSEcCtD
Cevimeline—Rash—Docetaxel—stomach cancer	0.000201	0.00024	CcSEcCtD
Cevimeline—Hypotension—Epirubicin—stomach cancer	0.000201	0.00024	CcSEcCtD
Cevimeline—Dermatitis—Docetaxel—stomach cancer	0.000201	0.00024	CcSEcCtD
Cevimeline—Confusional state—Doxorubicin—stomach cancer	0.000201	0.00024	CcSEcCtD
Cevimeline—Decreased appetite—Methotrexate—stomach cancer	0.0002	0.000239	CcSEcCtD
Cevimeline—Headache—Docetaxel—stomach cancer	0.0002	0.000239	CcSEcCtD
Cevimeline—Oedema—Doxorubicin—stomach cancer	0.000199	0.000238	CcSEcCtD
Cevimeline—Fatigue—Methotrexate—stomach cancer	0.000198	0.000237	CcSEcCtD
Cevimeline—Infection—Doxorubicin—stomach cancer	0.000198	0.000236	CcSEcCtD
Cevimeline—Pain—Methotrexate—stomach cancer	0.000196	0.000235	CcSEcCtD
Cevimeline—Vomiting—Capecitabine—stomach cancer	0.000196	0.000234	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000196	0.000234	CcSEcCtD
Cevimeline—Shock—Doxorubicin—stomach cancer	0.000196	0.000234	CcSEcCtD
Cevimeline—Nervous system disorder—Doxorubicin—stomach cancer	0.000195	0.000233	CcSEcCtD
Cevimeline—Thrombocytopenia—Doxorubicin—stomach cancer	0.000195	0.000233	CcSEcCtD
Cevimeline—Rash—Capecitabine—stomach cancer	0.000195	0.000232	CcSEcCtD
Cevimeline—Insomnia—Epirubicin—stomach cancer	0.000194	0.000232	CcSEcCtD
Cevimeline—Dermatitis—Capecitabine—stomach cancer	0.000194	0.000232	CcSEcCtD
Cevimeline—Tachycardia—Doxorubicin—stomach cancer	0.000194	0.000232	CcSEcCtD
Cevimeline—Headache—Capecitabine—stomach cancer	0.000193	0.000231	CcSEcCtD
Cevimeline—Skin disorder—Doxorubicin—stomach cancer	0.000193	0.000231	CcSEcCtD
Cevimeline—Paraesthesia—Epirubicin—stomach cancer	0.000193	0.000231	CcSEcCtD
Cevimeline—Hyperhidrosis—Doxorubicin—stomach cancer	0.000192	0.00023	CcSEcCtD
Cevimeline—Dyspnoea—Epirubicin—stomach cancer	0.000192	0.000229	CcSEcCtD
Cevimeline—Somnolence—Epirubicin—stomach cancer	0.000191	0.000228	CcSEcCtD
Cevimeline—Anorexia—Doxorubicin—stomach cancer	0.00019	0.000227	CcSEcCtD
Cevimeline—Nausea—Docetaxel—stomach cancer	0.000189	0.000226	CcSEcCtD
Cevimeline—Feeling abnormal—Methotrexate—stomach cancer	0.000189	0.000226	CcSEcCtD
Cevimeline—Dyspepsia—Epirubicin—stomach cancer	0.000189	0.000226	CcSEcCtD
Cevimeline—Gastrointestinal pain—Methotrexate—stomach cancer	0.000188	0.000224	CcSEcCtD
Cevimeline—Decreased appetite—Epirubicin—stomach cancer	0.000187	0.000223	CcSEcCtD
Cevimeline—Hypotension—Doxorubicin—stomach cancer	0.000186	0.000222	CcSEcCtD
Cevimeline—Fatigue—Epirubicin—stomach cancer	0.000185	0.000221	CcSEcCtD
Cevimeline—Constipation—Epirubicin—stomach cancer	0.000184	0.00022	CcSEcCtD
Cevimeline—Pain—Epirubicin—stomach cancer	0.000184	0.00022	CcSEcCtD
Cevimeline—Nausea—Capecitabine—stomach cancer	0.000183	0.000219	CcSEcCtD
Cevimeline—Urticaria—Methotrexate—stomach cancer	0.000183	0.000218	CcSEcCtD
Cevimeline—Abdominal pain—Methotrexate—stomach cancer	0.000182	0.000217	CcSEcCtD
Cevimeline—Body temperature increased—Methotrexate—stomach cancer	0.000182	0.000217	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000181	0.000217	CcSEcCtD
Cevimeline—Insomnia—Doxorubicin—stomach cancer	0.00018	0.000215	CcSEcCtD
Cevimeline—Paraesthesia—Doxorubicin—stomach cancer	0.000179	0.000213	CcSEcCtD
Cevimeline—Dyspnoea—Doxorubicin—stomach cancer	0.000177	0.000212	CcSEcCtD
Cevimeline—Feeling abnormal—Epirubicin—stomach cancer	0.000177	0.000212	CcSEcCtD
Cevimeline—Somnolence—Doxorubicin—stomach cancer	0.000177	0.000211	CcSEcCtD
Cevimeline—Gastrointestinal pain—Epirubicin—stomach cancer	0.000176	0.00021	CcSEcCtD
Cevimeline—Dyspepsia—Doxorubicin—stomach cancer	0.000175	0.000209	CcSEcCtD
Cevimeline—Decreased appetite—Doxorubicin—stomach cancer	0.000173	0.000207	CcSEcCtD
Cevimeline—Fatigue—Doxorubicin—stomach cancer	0.000172	0.000205	CcSEcCtD
Cevimeline—Urticaria—Epirubicin—stomach cancer	0.000171	0.000204	CcSEcCtD
Cevimeline—Pain—Doxorubicin—stomach cancer	0.00017	0.000203	CcSEcCtD
Cevimeline—Constipation—Doxorubicin—stomach cancer	0.00017	0.000203	CcSEcCtD
Cevimeline—Abdominal pain—Epirubicin—stomach cancer	0.00017	0.000203	CcSEcCtD
Cevimeline—Body temperature increased—Epirubicin—stomach cancer	0.00017	0.000203	CcSEcCtD
Cevimeline—Hypersensitivity—Methotrexate—stomach cancer	0.000169	0.000202	CcSEcCtD
Cevimeline—Asthenia—Methotrexate—stomach cancer	0.000165	0.000197	CcSEcCtD
Cevimeline—Feeling abnormal—Doxorubicin—stomach cancer	0.000164	0.000196	CcSEcCtD
Cevimeline—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000163	0.000194	CcSEcCtD
Cevimeline—Pruritus—Methotrexate—stomach cancer	0.000163	0.000194	CcSEcCtD
Cevimeline—Hypersensitivity—Epirubicin—stomach cancer	0.000158	0.000189	CcSEcCtD
Cevimeline—Urticaria—Doxorubicin—stomach cancer	0.000158	0.000189	CcSEcCtD
Cevimeline—Abdominal pain—Doxorubicin—stomach cancer	0.000157	0.000188	CcSEcCtD
Cevimeline—Body temperature increased—Doxorubicin—stomach cancer	0.000157	0.000188	CcSEcCtD
Cevimeline—Diarrhoea—Methotrexate—stomach cancer	0.000157	0.000188	CcSEcCtD
Cevimeline—Asthenia—Epirubicin—stomach cancer	0.000154	0.000184	CcSEcCtD
Cevimeline—Pruritus—Epirubicin—stomach cancer	0.000152	0.000182	CcSEcCtD
Cevimeline—Dizziness—Methotrexate—stomach cancer	0.000152	0.000182	CcSEcCtD
Cevimeline—Diarrhoea—Epirubicin—stomach cancer	0.000147	0.000176	CcSEcCtD
Cevimeline—Hypersensitivity—Doxorubicin—stomach cancer	0.000147	0.000175	CcSEcCtD
Cevimeline—Vomiting—Methotrexate—stomach cancer	0.000146	0.000175	CcSEcCtD
Cevimeline—Rash—Methotrexate—stomach cancer	0.000145	0.000173	CcSEcCtD
Cevimeline—Dermatitis—Methotrexate—stomach cancer	0.000145	0.000173	CcSEcCtD
Cevimeline—Headache—Methotrexate—stomach cancer	0.000144	0.000172	CcSEcCtD
Cevimeline—Asthenia—Doxorubicin—stomach cancer	0.000143	0.000171	CcSEcCtD
Cevimeline—Dizziness—Epirubicin—stomach cancer	0.000142	0.00017	CcSEcCtD
Cevimeline—Pruritus—Doxorubicin—stomach cancer	0.000141	0.000168	CcSEcCtD
Cevimeline—Vomiting—Epirubicin—stomach cancer	0.000137	0.000163	CcSEcCtD
Cevimeline—Nausea—Methotrexate—stomach cancer	0.000136	0.000163	CcSEcCtD
Cevimeline—Diarrhoea—Doxorubicin—stomach cancer	0.000136	0.000163	CcSEcCtD
Cevimeline—Rash—Epirubicin—stomach cancer	0.000136	0.000162	CcSEcCtD
Cevimeline—Dermatitis—Epirubicin—stomach cancer	0.000135	0.000162	CcSEcCtD
Cevimeline—Headache—Epirubicin—stomach cancer	0.000135	0.000161	CcSEcCtD
Cevimeline—Dizziness—Doxorubicin—stomach cancer	0.000132	0.000157	CcSEcCtD
Cevimeline—Nausea—Epirubicin—stomach cancer	0.000128	0.000153	CcSEcCtD
Cevimeline—Vomiting—Doxorubicin—stomach cancer	0.000127	0.000151	CcSEcCtD
Cevimeline—Rash—Doxorubicin—stomach cancer	0.000125	0.00015	CcSEcCtD
Cevimeline—Dermatitis—Doxorubicin—stomach cancer	0.000125	0.00015	CcSEcCtD
Cevimeline—Headache—Doxorubicin—stomach cancer	0.000125	0.000149	CcSEcCtD
Cevimeline—Nausea—Doxorubicin—stomach cancer	0.000118	0.000141	CcSEcCtD
Cevimeline—CHRM3—Signaling Pathways—FST—stomach cancer	5.78e-05	0.00051	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—ADRB2—stomach cancer	5.77e-05	0.000509	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PLIN2—stomach cancer	5.76e-05	0.000508	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—ADRB2—stomach cancer	5.75e-05	0.000507	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SUCLG1—stomach cancer	5.68e-05	0.000501	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—IDH3B—stomach cancer	5.68e-05	0.000501	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HBEGF—stomach cancer	5.68e-05	0.000501	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—TP53—stomach cancer	5.66e-05	0.0005	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HBEGF—stomach cancer	5.66e-05	0.000499	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CA2—stomach cancer	5.6e-05	0.000494	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RGS2—stomach cancer	5.6e-05	0.000494	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GAST—stomach cancer	5.6e-05	0.000494	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GAST—stomach cancer	5.58e-05	0.000492	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RGS2—stomach cancer	5.58e-05	0.000492	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	5.55e-05	0.000489	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	5.53e-05	0.000488	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NT5E—stomach cancer	5.46e-05	0.000481	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PGAM1—stomach cancer	5.46e-05	0.000481	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FGG—stomach cancer	5.31e-05	0.000468	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FGG—stomach cancer	5.29e-05	0.000467	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NDUFS1—stomach cancer	5.28e-05	0.000466	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NDUFV1—stomach cancer	5.28e-05	0.000466	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—ADRB2—stomach cancer	5.24e-05	0.000462	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—ADRB2—stomach cancer	5.22e-05	0.000461	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PLCE1—stomach cancer	5.21e-05	0.000459	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALDH7A1—stomach cancer	5.21e-05	0.000459	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—IL6—stomach cancer	5.18e-05	0.000457	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PPP2R1A—stomach cancer	5.13e-05	0.000453	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	5.13e-05	0.000453	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PPP2R1A—stomach cancer	5.12e-05	0.000451	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTT1—stomach cancer	5.12e-05	0.000451	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	5.12e-05	0.000451	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PRKAA1—stomach cancer	5.11e-05	0.000451	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PRKAA1—stomach cancer	5.09e-05	0.000449	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP2A6—stomach cancer	5.06e-05	0.000446	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—UMPS—stomach cancer	4.99e-05	0.00044	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RBP4—stomach cancer	4.93e-05	0.000435	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CXCL8—stomach cancer	4.93e-05	0.000435	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AKR1C3—stomach cancer	4.92e-05	0.000434	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RBP4—stomach cancer	4.92e-05	0.000434	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CXCL8—stomach cancer	4.91e-05	0.000434	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	4.91e-05	0.000433	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	4.9e-05	0.000432	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ENO1—stomach cancer	4.79e-05	0.000423	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—BLVRB—stomach cancer	4.71e-05	0.000415	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PGLS—stomach cancer	4.71e-05	0.000415	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PDHA1—stomach cancer	4.64e-05	0.000409	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ECHS1—stomach cancer	4.64e-05	0.000409	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—PIK3CA—stomach cancer	4.54e-05	0.000401	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPAP2A—stomach cancer	4.49e-05	0.000396	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—FADS1—stomach cancer	4.36e-05	0.000385	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—TYMP—stomach cancer	4.36e-05	0.000385	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CD44—stomach cancer	4.25e-05	0.000375	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HSPB1—stomach cancer	4.24e-05	0.000374	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AGTR2—stomach cancer	4.24e-05	0.000374	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HSPB1—stomach cancer	4.23e-05	0.000373	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AGTR2—stomach cancer	4.23e-05	0.000373	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—F2R—stomach cancer	4.19e-05	0.00037	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—BMP2—stomach cancer	4.19e-05	0.00037	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—F2R—stomach cancer	4.18e-05	0.000369	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—BMP2—stomach cancer	4.18e-05	0.000369	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKR1C3—stomach cancer	4.13e-05	0.000364	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKR1C3—stomach cancer	4.11e-05	0.000363	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SREBF2—stomach cancer	4.09e-05	0.00036	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR1A—stomach cancer	4.08e-05	0.00036	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR1A—stomach cancer	4.07e-05	0.000359	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—RORA—stomach cancer	4.04e-05	0.000356	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—FBP1—stomach cancer	4e-05	0.000353	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NDUFA2—stomach cancer	4e-05	0.000353	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CKB—stomach cancer	4e-05	0.000353	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CA1—stomach cancer	4e-05	0.000353	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PRKCB—stomach cancer	3.95e-05	0.000349	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ANXA1—stomach cancer	3.94e-05	0.000348	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PRKCB—stomach cancer	3.94e-05	0.000348	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ANXA1—stomach cancer	3.93e-05	0.000347	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADRB1—stomach cancer	3.82e-05	0.000337	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADRB1—stomach cancer	3.81e-05	0.000336	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALDOB—stomach cancer	3.78e-05	0.000334	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLIN2—stomach cancer	3.76e-05	0.000332	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CA2—stomach cancer	3.66e-05	0.000323	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RPS6—stomach cancer	3.65e-05	0.000322	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RPS6—stomach cancer	3.64e-05	0.000321	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPP2R1A—stomach cancer	3.62e-05	0.000319	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PRKCB—stomach cancer	3.59e-05	0.000317	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PRKCB—stomach cancer	3.58e-05	0.000316	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6ST—stomach cancer	3.58e-05	0.000315	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NT5E—stomach cancer	3.57e-05	0.000315	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PGAM1—stomach cancer	3.57e-05	0.000315	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6ST—stomach cancer	3.56e-05	0.000314	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTP1—stomach cancer	3.55e-05	0.000313	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALOX5—stomach cancer	3.52e-05	0.00031	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HMOX1—stomach cancer	3.5e-05	0.000309	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—DPYD—stomach cancer	3.46e-05	0.000305	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLCE1—stomach cancer	3.4e-05	0.0003	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALDH7A1—stomach cancer	3.4e-05	0.0003	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HBEGF—stomach cancer	3.35e-05	0.000296	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HBEGF—stomach cancer	3.34e-05	0.000295	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—TYMS—stomach cancer	3.3e-05	0.000291	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—UMPS—stomach cancer	3.26e-05	0.000288	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTM1—stomach cancer	3.26e-05	0.000287	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6R—stomach cancer	3.19e-05	0.000281	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6R—stomach cancer	3.18e-05	0.000281	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—RHOA—stomach cancer	3.17e-05	0.00028	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—RHOA—stomach cancer	3.16e-05	0.000279	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADRB2—stomach cancer	3.09e-05	0.000273	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADRB2—stomach cancer	3.08e-05	0.000272	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ERCC2—stomach cancer	3.06e-05	0.00027	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTT1—stomach cancer	3.06e-05	0.00027	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PDHA1—stomach cancer	3.03e-05	0.000268	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ECHS1—stomach cancer	3.03e-05	0.000268	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PPP2R1A—stomach cancer	3.03e-05	0.000268	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP2A6—stomach cancer	3.02e-05	0.000267	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PPP2R1A—stomach cancer	3.02e-05	0.000267	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AKR1C3—stomach cancer	2.94e-05	0.00026	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—RHOA—stomach cancer	2.88e-05	0.000254	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MTHFR—stomach cancer	2.88e-05	0.000254	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—RHOA—stomach cancer	2.87e-05	0.000253	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ENO1—stomach cancer	2.87e-05	0.000253	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—FADS1—stomach cancer	2.85e-05	0.000252	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—TYMP—stomach cancer	2.85e-05	0.000252	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SMAD4—stomach cancer	2.82e-05	0.000248	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SMAD4—stomach cancer	2.81e-05	0.000248	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CXCL8—stomach cancer	2.79e-05	0.000246	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CXCL8—stomach cancer	2.78e-05	0.000245	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FYN—stomach cancer	2.67e-05	0.000236	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SREBF2—stomach cancer	2.67e-05	0.000236	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FYN—stomach cancer	2.67e-05	0.000235	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CAV1—stomach cancer	2.66e-05	0.000234	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOA1—stomach cancer	2.65e-05	0.000234	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—RORA—stomach cancer	2.64e-05	0.000233	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CD44—stomach cancer	2.54e-05	0.000224	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CXCL8—stomach cancer	2.53e-05	0.000223	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CXCL8—stomach cancer	2.52e-05	0.000223	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FGFR2—stomach cancer	2.51e-05	0.000221	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FGFR2—stomach cancer	2.5e-05	0.000221	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALDOB—stomach cancer	2.47e-05	0.000218	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPARG—stomach cancer	2.34e-05	0.000206	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALOX5—stomach cancer	2.3e-05	0.000203	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IRS2—stomach cancer	2.3e-05	0.000203	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IRS2—stomach cancer	2.29e-05	0.000202	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—DPYD—stomach cancer	2.26e-05	0.0002	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CAV1—stomach cancer	2.23e-05	0.000197	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOA1—stomach cancer	2.22e-05	0.000196	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CAV1—stomach cancer	2.22e-05	0.000196	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOA1—stomach cancer	2.22e-05	0.000196	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPP2R1A—stomach cancer	2.16e-05	0.000191	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PRKCB—stomach cancer	2.12e-05	0.000187	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTP1—stomach cancer	2.12e-05	0.000187	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PRKCB—stomach cancer	2.11e-05	0.000187	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6ST—stomach cancer	2.11e-05	0.000186	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6ST—stomach cancer	2.11e-05	0.000186	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ALB—stomach cancer	2.1e-05	0.000185	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HMOX1—stomach cancer	2.09e-05	0.000184	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APC—stomach cancer	2.03e-05	0.000179	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APC—stomach cancer	2.02e-05	0.000179	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NOS3—stomach cancer	2.01e-05	0.000177	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTT1—stomach cancer	2e-05	0.000176	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.98e-05	0.000174	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—TYMS—stomach cancer	1.97e-05	0.000174	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTM1—stomach cancer	1.95e-05	0.000172	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—MAPK3—stomach cancer	1.94e-05	0.000171	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—MAPK3—stomach cancer	1.94e-05	0.000171	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.92e-05	0.00017	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6R—stomach cancer	1.88e-05	0.000166	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6R—stomach cancer	1.88e-05	0.000166	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ENO1—stomach cancer	1.87e-05	0.000165	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	1.85e-05	0.000163	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—EGFR—stomach cancer	1.85e-05	0.000163	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—MAPK1—stomach cancer	1.84e-05	0.000163	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—EGFR—stomach cancer	1.84e-05	0.000163	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTGS2—stomach cancer	1.84e-05	0.000162	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ERCC2—stomach cancer	1.83e-05	0.000162	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	1.77e-05	0.000156	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	1.76e-05	0.000156	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PIK3CA—stomach cancer	1.76e-05	0.000155	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SERPINE1—stomach cancer	1.76e-05	0.000155	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—KRAS—stomach cancer	1.75e-05	0.000154	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—KRAS—stomach cancer	1.74e-05	0.000154	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MTHFR—stomach cancer	1.72e-05	0.000152	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RHOA—stomach cancer	1.7e-05	0.00015	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RHOA—stomach cancer	1.7e-05	0.00015	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOS3—stomach cancer	1.69e-05	0.000149	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOS3—stomach cancer	1.68e-05	0.000148	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CD44—stomach cancer	1.66e-05	0.000147	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	1.61e-05	0.000142	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3CA—stomach cancer	1.6e-05	0.000141	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CAV1—stomach cancer	1.59e-05	0.00014	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOA1—stomach cancer	1.58e-05	0.00014	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ERBB2—stomach cancer	1.58e-05	0.000139	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ERBB2—stomach cancer	1.57e-05	0.000139	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCL8—stomach cancer	1.49e-05	0.000132	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCL8—stomach cancer	1.49e-05	0.000131	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HRAS—stomach cancer	1.48e-05	0.000131	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HRAS—stomach cancer	1.48e-05	0.000131	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	1.46e-05	0.000129	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	1.46e-05	0.000128	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6—stomach cancer	1.42e-05	0.000125	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6—stomach cancer	1.42e-05	0.000125	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.41e-05	0.000125	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARG—stomach cancer	1.4e-05	0.000123	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCND1—stomach cancer	1.39e-05	0.000123	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—JUN—stomach cancer	1.39e-05	0.000123	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCND1—stomach cancer	1.39e-05	0.000122	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTP1—stomach cancer	1.39e-05	0.000122	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—JUN—stomach cancer	1.39e-05	0.000122	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HMOX1—stomach cancer	1.37e-05	0.000121	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MMP9—stomach cancer	1.35e-05	0.000119	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MMP9—stomach cancer	1.35e-05	0.000119	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	1.35e-05	0.000119	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	1.34e-05	0.000118	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MAPK8—stomach cancer	1.31e-05	0.000116	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MAPK8—stomach cancer	1.31e-05	0.000116	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—TYMS—stomach cancer	1.29e-05	0.000114	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTM1—stomach cancer	1.27e-05	0.000112	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALB—stomach cancer	1.26e-05	0.000111	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VEGFA—stomach cancer	1.21e-05	0.000107	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VEGFA—stomach cancer	1.21e-05	0.000107	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—STAT3—stomach cancer	1.2e-05	0.000106	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NOS3—stomach cancer	1.2e-05	0.000106	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—STAT3—stomach cancer	1.2e-05	0.000106	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ERCC2—stomach cancer	1.2e-05	0.000106	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MAPK3—stomach cancer	1.15e-05	0.000101	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MAPK3—stomach cancer	1.14e-05	0.000101	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CA—stomach cancer	1.13e-05	9.97e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MTHFR—stomach cancer	1.13e-05	9.93e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MYC—stomach cancer	1.12e-05	9.85e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MYC—stomach cancer	1.11e-05	9.82e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTGS2—stomach cancer	1.1e-05	9.69e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MAPK1—stomach cancer	1.09e-05	9.64e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EGFR—stomach cancer	1.09e-05	9.64e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MAPK1—stomach cancer	1.09e-05	9.61e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EGFR—stomach cancer	1.09e-05	9.61e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CAV1—stomach cancer	1.04e-05	9.16e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOA1—stomach cancer	1.04e-05	9.14e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—KRAS—stomach cancer	1.03e-05	9.1e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—KRAS—stomach cancer	1.03e-05	9.08e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	9.48e-06	8.36e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	9.45e-06	8.34e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TP53—stomach cancer	9.17e-06	8.09e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TP53—stomach cancer	9.14e-06	8.07e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARG—stomach cancer	9.13e-06	8.05e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HRAS—stomach cancer	8.77e-06	7.74e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HRAS—stomach cancer	8.74e-06	7.71e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6—stomach cancer	8.4e-06	7.41e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6—stomach cancer	8.37e-06	7.38e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALB—stomach cancer	8.21e-06	7.24e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NOS3—stomach cancer	7.85e-06	6.93e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTGS2—stomach cancer	7.18e-06	6.34e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CA—stomach cancer	6.76e-06	5.96e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CA—stomach cancer	4.42e-06	3.9e-05	CbGpPWpGaD
